Document Detail


Cdc5L interacts with ATR and is required for the S-phase cell-cycle checkpoint.
MedLine Citation:
PMID:  19633697     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cell division cycle 5-like protein (Cdc5L) is a core component of the putative E3 ubiquitin ligase complex containing Prp19/Pso4, Plrg1 and Spf27. This complex has been shown to have a role in pre-messenger RNA splicing from yeast to humans; however, more recent studies have described a function for this complex in the cellular response to DNA damage. Here, we show that Cdc5L interacts physically with the cell-cycle checkpoint kinase ataxia-telangiectasia and Rad3-related (ATR). Depletion of Cdc5L by RNA-mediated interference methods results in a defective S-phase cell-cycle checkpoint and cellular sensitivity in response to replication-fork blocking agents. Furthermore, we show that Cdc5L is required for the activation of downstream effectors or mediators of ATR checkpoint function such as checkpoint kinase 1 (Chk1), cell cycle checkpoint protein Rad 17 (Rad17) and Fanconi anaemia complementation group D2 protein (FancD2). In addition, we have mapped the ATR-binding region in Cdc5L and show that a deletion mutant that is unable to interact with ATR is defective in the rescue of the checkpoint deficiency in Cdc5L-depleted cells. These findings show a new function for Cdc5L in the regulation of the ATR-mediated cell-cycle checkpoint in response to genotoxic agents.
Authors:
Nianxiang Zhang; Ramandeep Kaur; Shamima Akhter; Randy J Legerski
Related Documents :
19597327 - The cyclin-dependent kinase inhibitors, cki-1 and cki-2, act in overlapping but distinc...
8380637 - Regulation of cell cycle progression and nuclear affinity of the retinoblastoma protein...
15201157 - Modulation of the cardiomyocyte cell cycle in genetically altered animals.
8986717 - A conserved degradation signal regulates rag-2 accumulation during cell division and li...
19597327 - The cyclin-dependent kinase inhibitors, cki-1 and cki-2, act in overlapping but distinc...
19780757 - Distinctive cell properties of b cells carrying the bcl2 translocation and their potent...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2009-07-24
Journal Detail:
Title:  EMBO reports     Volume:  10     ISSN:  1469-3178     ISO Abbreviation:  EMBO Rep.     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-01     Completed Date:  2009-11-10     Revised Date:  2010-09-02    
Medline Journal Info:
Nlm Unique ID:  100963049     Medline TA:  EMBO Rep     Country:  England    
Other Details:
Languages:  eng     Pagination:  1029-35     Citation Subset:  IM    
Affiliation:
Department of Genetics, The University of Texas MD Anderson Cancer Center, University of Texas, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Cycle Proteins / genetics,  metabolism*
Cell Line
DNA Damage
Humans
Mutation
Protein Binding
Protein-Serine-Threonine Kinases / genetics,  metabolism*
RNA, Small Interfering / genetics
RNA-Binding Proteins / genetics,  metabolism*
S Phase*
Grant Support
ID/Acronym/Agency:
CA097175/CA/NCI NIH HHS; CA16672/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/CDC5L protein, human; 0/Cell Cycle Proteins; 0/RNA, Small Interfering; 0/RNA-Binding Proteins; EC 2.7.1.-/ATR protein, human; EC 2.7.11.1/Protein-Serine-Threonine Kinases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  HAT-HDAC interplay modulates global histone H3K14 acetylation in gene-coding regions during stress.
Next Document:  Observation of the density and size of cells in hippocampus and vascular lesion in thalamus of GFAP-...